BioWorld Asia

July 20, 2005

Researchers Find Shared Secrets Of Neglected Parasitic Diseases

Veteran Stem Cell Company Raises £6M On London's AIM

Xention's Third Round Gets £11M For Ion Channel Drugs

Other News To Note

Arakis Providing Exit Via £106.5M Sosei Acquisition

LONDON - Sosei Co Ltd. is taking over Arakis Ltd. for £106.5 million (US$187.4 million) in a cash-and-shares deal that creates an Anglo-Japanese company valued at £278 million. (BioWorld International) Read More

Roche Acquiring GlycArt Through CHF235M Buyout

Today's news in brief

BioWorld

BioWorld briefs for Dec. 24, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 24, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...